{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:09:48Z","timestamp":1780463388869,"version":"3.54.1"},"reference-count":47,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,11,30]]},"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore the extent to which undervaccinated subpopulations may influence the confidence about no circulation of wild poliovirus (WPV) after the last detected case.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and participants<\/jats:title><jats:p>We used a hypothetical model to examine the extent to which the existence of an undervaccinated subpopulation influences the confidence about no WPV circulation after the last detected case as a function of different characteristics of the subpopulation (eg, size, extent of isolation). We also used the hypothetical population model to inform the bounds on the maximum possible time required to reach high confidence about no circulation in a completely isolated and unvaccinated subpopulation starting either at the endemic equilibrium or with a single infection in an entirely susceptible population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>It may take over 3\u2009years to reach 95% confidence about no circulation for this hypothetical population despite high surveillance sensitivity and high vaccination coverage in the surrounding general population if: (1) ability to detect cases in the undervaccinated subpopulation remains exceedingly small, (2) the undervaccinated subpopulation remains small and highly isolated from the general population and (3) the coverage in the undervaccinated subpopulation remains very close to the minimum needed to eradicate. Fully-isolated hypothetical populations of 4000 people or less cannot sustain endemic transmission for more than 5 years, with at least 20\u2009000 people required for a 50% chance of at least 5 years of sustained transmission in a population without seasonality that starts at the endemic equilibrium. Notably, however, the population size required for persistent transmission increases significantly for realistic populations that include some vaccination and seasonality and\/or that do not begin at the endemic equilibrium.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Significant trade-offs remain inherent in global polio certification decisions, which underscore the need for making and valuing investments to maximise population immunity and surveillance quality in all remaining possible WPV reservoirs.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2018-023938","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T19:55:55Z","timestamp":1547582155000},"page":"e023938","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Global certification of wild poliovirus eradication: insights from modelling hard-to-reach subpopulations and confidence about the absence of transmission"],"prefix":"10.1136","volume":"9","author":[{"given":"Radboud J","family":"Duintjer Tebbens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika A","family":"Kalkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"2024051714123433000_9.1.e023938.1","unstructured":"World HealthAssembly. Global eradication of poliomyelitis by the year 2000 (resolution 41.28. Geneva: World Health Organization, 1988."},{"key":"2024051714123433000_9.1.e023938.2","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12044"},{"key":"2024051714123433000_9.1.e023938.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2012.01891.x"},{"key":"2024051714123433000_9.1.e023938.4","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.vaccine.2015.02.013","article-title":"Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses","volume":"33","author":"Thompson","year":"2015","journal-title":"Vaccine"},{"key":"2024051714123433000_9.1.e023938.5","first-page":"190","article-title":"The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation","volume":"10","author":"Thompson","year":"2008","journal-title":"Medscape J Med"},{"key":"2024051714123433000_9.1.e023938.6","unstructured":"\u00a0World Health Organization. Global polio eradication initiative: polio eradication and endgame strategic plan (2013-2018). Geneva: World Health Organization, 2013."},{"key":"2024051714123433000_9.1.e023938.7","unstructured":"World Health Assembly. Poliomyelitis: mechanism for management of potential risks to eradication (resolution 61.1. Geneva: World Health Organization, 2008."},{"key":"2024051714123433000_9.1.e023938.8","unstructured":"\u00a0Global Polio Eradication Initiative. Global eradication of wild poliovirus type 2 declared 2015. 2015 http:\/\/www.polioeradication.org\/mediaroom\/newsstories\/Global-eradication-of-wild-poliovirus-type-2-declared\/tabid\/526\/news\/1289\/Default.aspx (Accessed 30 Nov 2015)."},{"key":"2024051714123433000_9.1.e023938.9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6535a3"},{"key":"2024051714123433000_9.1.e023938.10","unstructured":"\u00a0World Health Organization. Polio this week as of 2018. 2018 http:\/\/polioeradication.org\/polio-today\/polio-now\/this-week\/"},{"key":"2024051714123433000_9.1.e023938.11","first-page":"1031","article-title":"Possible eradication of wild poliovirus type 3--worldwide, 2012","volume":"63","author":"Kew","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024051714123433000_9.1.e023938.12","unstructured":"\u00a0World Health Organization. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2004-June 2005. Weekly Epidemiological Record 2005;80:335\u201340."},{"key":"2024051714123433000_9.1.e023938.13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.15585\/mmwr.mm6607a2","article-title":"Continued endemic wild poliovirus transmission in security-compromised areas - Nigeria, 2016","volume":"66","author":"Nnadi","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024051714123433000_9.1.e023938.14","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq320"},{"key":"2024051714123433000_9.1.e023938.15","first-page":"95","article-title":"Transmission of wild poliovirus type 2--apparent global interruption","volume":"76","author":"\u00a0World Health Organization","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"key":"2024051714123433000_9.1.e023938.16","first-page":"217","article-title":"Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003","volume":"118","author":"Deshpande","year":"2003","journal-title":"Indian J Med Res"},{"key":"2024051714123433000_9.1.e023938.17","doi-asserted-by":"crossref","unstructured":"Duizer E , Ruijs WL , van der Weijden CP , et al . Response to a wild poliovirus type 2 (WPV2)-shedding event following accidental exposure to WPV2, the Netherlands, April 2017. Euro Surveill 2017;22.doi:10.2807\/1560-7917.ES.2017.22.21.30542","DOI":"10.2807\/1560-7917.ES.2017.22.21.30542"},{"key":"2024051714123433000_9.1.e023938.18","first-page":"720","article-title":"Certification of poliomyelitis eradication--the Americas, 1994","volume":"43","author":"\u00a0Centers for Disease Control and Prevention (CDC)","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024051714123433000_9.1.e023938.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-5564(98)00007-8"},{"key":"2024051714123433000_9.1.e023938.20","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008820"},{"key":"2024051714123433000_9.1.e023938.21","doi-asserted-by":"publisher","DOI":"10.1016\/0025-5564(94)00046-3"},{"key":"2024051714123433000_9.1.e023938.22","doi-asserted-by":"crossref","unstructured":"Eichner M , Hadeler KP , Dietz K . Stochastic models for the eradication of poliomyelitis: minimum population size for polio virus persistence. In: Isham V , Medley GF , eds. Models for Infectious human diseases: their structure and relation to data.. New York: Cambridge University Press, 1996:315\u201327.","DOI":"10.1017\/CBO9780511662935.048"},{"key":"2024051714123433000_9.1.e023938.23","unstructured":"World Health Organization. Global polio eradication initiative: strategic plan 2004-2008. Geneva: World Health Organization, 2004."},{"key":"2024051714123433000_9.1.e023938.24","first-page":"941","article-title":"Polio-free certification and lessons learned--South-East Asia region, March 2014","volume":"63","author":"Bahl","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024051714123433000_9.1.e023938.25","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr399"},{"key":"2024051714123433000_9.1.e023938.26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jtbi.2015.06.046","article-title":"The probability of undetected wild poliovirus circulation: Can we do better?","volume":"382","author":"Houy","year":"2015","journal-title":"J Theor Biol"},{"key":"2024051714123433000_9.1.e023938.27","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-014-0722-x"},{"key":"2024051714123433000_9.1.e023938.28","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit844"},{"key":"2024051714123433000_9.1.e023938.29","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit834"},{"key":"2024051714123433000_9.1.e023938.30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-45"},{"key":"2024051714123433000_9.1.e023938.31","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu674"},{"key":"2024051714123433000_9.1.e023938.32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6786"},{"key":"2024051714123433000_9.1.e023938.33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135765","article-title":"Has Wild Poliovirus Been Eliminated from Nigeria?","volume":"10","author":"Famulare","year":"2016","journal-title":"PLoS One"},{"key":"2024051714123433000_9.1.e023938.34","first-page":"431","article-title":"Silent circulation of poliovirus in small populations","volume":"2","author":"Vallejo","year":"2017","journal-title":"Infect Dis Model"},{"key":"2024051714123433000_9.1.e023938.35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.idm.2018.02.001","article-title":"Corrigendum to\u00a0\u201cSilent circulation of poliovirus in small populations\u201d","volume":"3","author":"Vallejo","year":"2018","journal-title":"Infectious Disease Modelling"},{"key":"2024051714123433000_9.1.e023938.36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.idm.2018.06.001","article-title":"Another look at silent circulation of poliovirus in small populations","volume":"3","author":"Kalkowska","year":"2018","journal-title":"Infectious Disease Modelling"},{"key":"2024051714123433000_9.1.e023938.37","unstructured":"\u00a0World Health Organization. Report on polio transition planning - advance draft as of 18 April, 2017. 2017 http:\/\/www.who.int\/mediacentre\/events\/2017\/advance-report-polio-transmission.pdf?ua=1 (Accessed 12 March 2018)."},{"issue":"suppl_1","key":"2024051714123433000_9.1.e023938.38","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1093\/infdis\/jix108","article-title":"Lessons from the polio endgame: overcoming the failure to vaccinate and the role of subpopulations in maintaining transmission","volume":"216","author":"Thompson","year":"2017","journal-title":"J Infect Dis"},{"key":"2024051714123433000_9.1.e023938.39","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9991(76)90041-3"},{"key":"2024051714123433000_9.1.e023938.40","unstructured":"Sterman J . Business dynamics: Systems thinking and modeling for a complex world. Boston, MA: \u00a0McGraw-Hill, 2000."},{"key":"2024051714123433000_9.1.e023938.41","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/risa.12962","article-title":"Modeling poliovirus transmission in pakistan and afghanistan to inform vaccination strategies in undervaccinated subpopulations","volume":"38","author":"Duintjer Tebbens","year":"2018","journal-title":"Risk Anal"},{"key":"2024051714123433000_9.1.e023938.42","unstructured":"\u00a0Global Polio Eradication Initiative. Guidelines on environmental surveillance for detection of polioviruses - working draft. 2015."},{"key":"2024051714123433000_9.1.e023938.43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12560-017-9314-4","article-title":"Insights from a systematic search for information on designs, costs, and effectiveness of poliovirus environmental surveillance systems","volume":"9","author":"Duintjer Tebbens","year":"2017","journal-title":"Food Environ Virol"},{"key":"2024051714123433000_9.1.e023938.44","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2013.18.38.20586"},{"key":"2024051714123433000_9.1.e023938.45","doi-asserted-by":"crossref","unstructured":"Kalkowska DA , Duintjer Tebbens RJ , Thompson KM . Environmental surveillance system characteristics and impacts on confidence about no undetected serotype 1 wild poliovirus circulation. Risk Anal 2018;62.doi:10.1111\/risa.13193","DOI":"10.1111\/risa.13193"},{"key":"2024051714123433000_9.1.e023938.46","doi-asserted-by":"publisher","DOI":"10.1177\/003335491212700104"},{"key":"2024051714123433000_9.1.e023938.47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/14760584.2018.1506333","article-title":"Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine","volume":"17","author":"Duintjer Tebbens","year":"2018","journal-title":"Expert Rev Vaccines"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-023938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:35:50Z","timestamp":1715992550000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-023938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,15]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1136\/bmjopen-2018-023938"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-023938","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}